Today, stem cell therapies are also being studied at the University of Illinois at Chicago College of Medicine to prevent acute lung injuries. Embryonic, placental, and umbilical cord stem cell treatments and research continues to focus on unlimited potential to treat, reduce the symptoms of, and perhaps potentially cure, degenerative disease processes such as Parkinson’s, Huntington’s, Alzheimer’s, and medical conditions like diabetes, heart disease, and cancer.

Facilities throughout the world, including those in stem cell treatment facilities in Mexico, the Ukraine, South Korea, and Western Europe continue to research adult stem cells, stem cell therapies, and potential stem cell treatments for everything from chronic illnesses to repairing heart, lung, or brain tissue damage by injury or disease processes.

Recently, over $230 million dollars in grants was awarded to a variety of California companies and universities for basic stem cell research in the treatment of diseases like AIDS and cancer.  Today, most stem cell research and development is non embryonic in nature, but individuals anxiously awaiting the legalization of stem cell treatments and procedures in the United States may have some time to wait, prompting many citizens to travel to facilities such as that of Integra, with Dr. Omar Gonzalez or ProgenCell, located in Mexico, or EmCell facilities, located in the Ukraine.

In an effort to hasten the availability of stem cell treatment and research in the United States, a group of American doctors have formed the American Stem Cell Therapy Association, encouraging FDA approval of stem cell research.  Until then, Americans are traveling abroad to reap the benefits of stem cell research and technology.